Anna B. Halpern
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 52
- Acute Myeloid Leukemia Research 42
- Chronic Myeloid Leukemia Treatments 15
- Multiple Myeloma Research and Treatments 9
- Genetics 30
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Roland B. Walter (50 shared papers)Elihu H. Estey (34 shared papers)Megan Othus (29 shared papers)Frederick R. Appelbaum (5 shared papers)Marco Mielcarek (4 shared papers)Daisuke Araki (4 shared papers)Jerald P. Radich (6 shared papers)Yi Zhou (4 shared papers)
- Journals
- Blood (25 papers)Journal of Clinical Oncology (8 papers)Leukemia (6 papers)Blood Advances (3 papers)Journal of the National Comprehensive Cancer Network (3 papers)
- Partner nations
- United StatesSouth AfricaSpain
In The Last Decade
Anna B. Halpern
61 papers receiving 898 citations
Peers
Comparison fields: 5 of 64
- Hematology 674
- Genetics 216
- Public Health, Environmental and Occupational Health 285
- Oncology 216
- Emergency Medicine 57
Countries citing papers authored by Anna B. Halpern
This map shows the geographic impact of Anna B. Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna B. Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna B. Halpern more than expected).
Fields of papers citing papers by Anna B. Halpern
This network shows the impact of papers produced by Anna B. Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna B. Halpern. The network helps show where Anna B. Halpern may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna B. Halpern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 258 | |
| 2 | 2016 | 145 | |
| 3 | 2012 | 61 | |
| 4 | 2016 | 56 | |
| 5 | 2015 | 44 | |
| 6 | 2009 | 38 | |
| 7 | 2018 | 34 | |
| 8 | 2020 | 31 | |
| 9 | 2017 | 25 | |
| 10 | 2018 | 24 | |
| 11 | 2020 | 18 | |
| 12 | 2019 | 17 | |
| 13 | 2020 | 15 | |
| 14 | 2019 | 14 | |
| 15 | 2014 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2022 | 6 | |
| 18 | 2008 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2020 | 5 |
About Anna B. Halpern
Anna B. Halpern is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Molecular Biology, having authored 74 papers that have together received 907 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Neutropenia and Cancer Infections (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Hematology (674 citations), Genetics (216 citations), Public Health, Environmental and Occupational Health (285 citations), Oncology (216 citations) and Emergency Medicine (57 citations). Anna B. Halpern has collaborated with scholars based in United States, South Africa and Spain. Frequent co-authors include Roland B. Walter, Elihu H. Estey, Megan Othus, Frederick R. Appelbaum, Marco Mielcarek, Daisuke Araki, Jerald P. Radich, Yi Zhou, Brent L. Wood and Gary H. Lyman. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Blood Advances and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.